Rapid responses are electronic comments to the editor. They enable our users
to debate issues raised in articles published on bmj.com. A rapid response
is first posted online. If you need the URL (web address) of an individual
response, simply click on the response headline and copy the URL from the
browser window. A proportion of responses will, after editing, be published
online and in the print journal as letters, which are indexed in PubMed.
Rapid responses are not indexed in PubMed and they are not journal articles.
The BMJ reserves the right to remove responses which are being
wilfully misrepresented as published articles or when it is brought to our
attention that a response spreads misinformation.
From March 2022, the word limit for rapid responses will be 600 words not
including references and author details. We will no longer post responses
that exceed this limit.
The word limit for letters selected from posted responses remains 300 words.
Newer drugs keep flooding the markets with all promises. There are
market forces involved that will keep generating the hype about the
efficacy and the utility of every new drug that is being churned out from
the drug factories. It is for the fraternity to be vigilant about tall
claims. Must we not desist from haste and involve a more cautious
approach to using newer drugs.
Regards.
•Dr. Akhilesh Kumar Singh. MBBS, MD
Sr Resident Neurology
•Dr. Parul Kushwah. MBBS, MISMCD
Family Medicine Practitioner.
•Dr. Rajesh Chauhan. MBBS, DFM, FCGP, ADHA, FISCD
Consultant, Family Medicine & Communicable Diseases.
Why the haste in using newer drugs?
Dear Editor,
Newer drugs keep flooding the markets with all promises. There are
market forces involved that will keep generating the hype about the
efficacy and the utility of every new drug that is being churned out from
the drug factories. It is for the fraternity to be vigilant about tall
claims. Must we not desist from haste and involve a more cautious
approach to using newer drugs.
Regards.
•Dr. Akhilesh Kumar Singh. MBBS, MD
Sr Resident Neurology
•Dr. Parul Kushwah. MBBS, MISMCD
Family Medicine Practitioner.
•Dr. Rajesh Chauhan. MBBS, DFM, FCGP, ADHA, FISCD
Consultant, Family Medicine & Communicable Diseases.
Competing interests:
None declared
Competing interests: No competing interests